162 Cases Of Chronic Obstructive Pulmonary Disease Treating Patients Condition Analysis

Objective:Understand Chinese medicine hospitals of xinjiang uygur autonomous region of chronic obstructive pulmonary disease (COPD) treating patients condition, professional knowledge training, Professional knowledge for clinical physician and patient mission provide data training. Methods:2010 September to November, to 2010 in xinjiang medical university affiliated hospital of traditional breathing a branch, breathing two families of hospitalization 162 cases of patients with COPD nearly march medication face-to-face condition investigation. Results:162 cases of patients with COPD age 50-89 in between, with an average age of 67.41 years; Male patients accounted for example), (97 per cent of female patients (65 cases),40.1 female ratio is:1.49:1 (male:female); Han 104 cases of patients, minority patients 58 cases; Moderate patients with COPD in 53, severe patients with COPD 69 cases, extremely seere COPD patients in 40 cases; Accept antibiotic treatment of patients 153 cases, used glucocorticoid therapy (including vein, inhaled, oral therapy) 131 patients with patients treated, eliminating phlegm to medicine, 87 cases of patients with diastolic agent treatment of bronchial 145 cases, (including use with 2 agonist 87 cases, anticholinergic activity 102 cases, theophylline drugs 127 patients), three of the bronchial diastolic agent all USES 89 cases of patients; But the immunomodulator treatment, the vaccine only 52 cases and use respectively in 5 cases; Drug treatment scheme combined herbs or proprietary Chinese medicine treatment of patients with 105 cases, use 3 kinds of above (including three) drug treatment of patients for 121 patients. Selection of drugs in treatment of antibiotics, bronchial diastolic agent, corticosteroids are used extensively, and immunity regulator, the use situation of the vaccine is poor; Male, female patients with drugs, male patients with COPD situation comparison drug treatment of antibiotics, glucocorticoid, the use of immune modulators than women (P< 0.05), but the vaccine, China or Chinese herbal medicine and joint use drugs significantly lower female patients (P< 0.05).162 cases according to age among patients with COPD analyze its drug status:four groups age patients for comparison drug treatment of antibiotics, found the use of bronchial diastolic agent, and the rest no obvious difference medications for drug use situation there exists significant difference between each age. Among them, more than 70 patients age phlegm glucocorticoid pills, obviously higher than using situation under 70 patients, and vaccine use increased with age, antibiotics, and gradually reduce the use of bronchial diastolic agent has no obvious difference; Different classification chronic obstructive pulmonary disease treating patients condition compared to severely, very severely COPD patients to antibiotics, glucocorticoid, bronchial diastolic agent, three drugs to use a combination of up to 100%; As his illness aggravating, vaccines, proprietary Chinese medicine or Chinese medicine usage down gradually. Conclusions:Chronic obstructive pulmonary disease in older men, for its district clinicians drug therapy is not standard. Various treatment drug antibiotics, glucocorticoid, bronchial diastolic agent were higher, and use the use of immunological regulator and vaccines in the district for drug therapy COPD are ignored, combination and join the TCM medicine treatment plan features still need positive publicity. Drug therapy patients with COPD not only needs the positive alleviate episode symptoms, we should pay more attention to the preventative medicine treatment to reduce the recurrence of COPD.